Glynn, Robert J.

A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission

Guralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology

Frailty in Older AdultsBalance, Gait, and Falls Prevention

Cited by 9,792

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine

Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular Diseases

Cited by 6,674

Variable Selection for Propensity Score Models

Brookhart, M. A., Schneeweiss, S., Rothman, K. J., Glynn, R. J., Avorn, J., & Stürmer, T. (2006) · American Journal of Epidemiology

Advanced Causal Inference TechniquesStatistical Methods in Epidemiology

Cited by 2,336

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.

Schneeweiss, S., Rassen, J. A., Glynn, R. J., Avorn, J., Mogun, H., & Brookhart, M. A. (2009) · Epidemiology

Advanced Causal Inference TechniquesStatistical Methods in Epidemiology

Cited by 1,128

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Kastelein, J. J., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · The Lancet

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 1,010

A combined comorbidity score predicted mortality in elderly patients better than existing scores

Gagne, J. J., Glynn, R. J., Avorn, J., Levin, R., & Schneeweiss, S. (2011) · Journal of Clinical Epidemiology

Chronic Disease Management StrategiesFrailty in Older Adults

Cited by 995

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

Ridker, P. M., Pradhan, A., MacFadyen, J. G., Libby, P., & Glynn, R. J. (2012) · The Lancet

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 816

Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure

Everett, B. M., Cornel, J. H., Lainscak, M., Anker, S. D., Abbate, A., Thuren, T., Libby, P., Glynn, R. J., & Ridker, P. M. (2019) · Circulation

Heart Failure Treatment and ManagementCardiac Fibrosis and Remodeling

Cited by 658

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

Ridker, P. M., Revkin, J., Amarenco, P., Brunell, R., Curto, M., Civeira, F., Flather, M., Glynn, R. J., Gregoire, J., Jukema, J. W., et al. (2017) · New England Journal of Medicine

Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular Diseases

Cited by 624

The Wilcoxon signed rank test for paired comparisons of clustered data

Rosner, B., Glynn, R. J., & Lee, M. T. (2006) · Biometrics

Statistical Methods in Clinical TrialsProbability and Statistical Research

Cited by 557

Indications for propensity scores and review of their use in pharmacoepidemiology

Glynn, R. J., Schneeweiss, S., & Stürmer, T. (2006) · Basic & Clinical Pharmacology & Toxicology

Advanced Causal Inference TechniquesStatistical Methods in Epidemiology

Cited by 541

Cholesterol and the risk of renal dysfunction in apparently healthy men

Schaeffner, E. S., Kurth, T., Curhan, G. C., Glynn, R. J., Rexrode, K. M., Baigent, C., Buring, J. E., & Gaziano, J. M. (2003) · Journal of the American Society of Nephrology

Chronic Kidney Disease and DiabetesLipoproteins and Cardiovascular Health

Cited by 442

Lipid-reduction variability and antidrug-antibody formation with bococizumab

Ridker, P. M., Tardif, J.-C., Amarenco, P., Duggan, W., Glynn, R. J., Jukema, J. W., Kastelein, J. J. P., Kim, A. M., Koenig, W., Nissen, S., et al. (2017) · New England Journal of Medicine

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 369

Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis

Everett, B. M., Pradhan, A. D., Solomon, D. H., Paynter, N., MacFadyen, J., Zaharris, E., Gupta, M., Clearfield, M., Libby, P., Hasan, A. A. K., et al. (2013) · American Heart Journal

Atherosclerosis and Cardiovascular DiseasesInflammatory Biomarkers in Disease Prognosis

Cited by 368

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

Pradhan, A. D., Paynter, N. P., Everett, B. M., Glynn, R. J., Amarenco, P., Elam, M., Ginsberg, H., Hiatt, W. R., Ishibashi, S., Koenig, W., et al. (2018) · American Heart Journal

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 319

Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study

Kim, D. H., Glynn, R. J., Avorn, J., Lipsitz, L. A., Rockwood, K., Pawar, A., & Schneeweiss, S. (2019) · The Journals of Gerontology: Series A

Frailty in Older AdultsChronic Disease Management Strategies

Cited by 285

Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events

Albert, M. A., Glynn, R. J., Buring, J., & Ridker, P. M. (2006) · Circulation

Health disparities and outcomesCardiovascular Health and Risk Factors

Cited by 262

Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial

Glynn, R. J., Koenig, W., Nordestgaard, B. G., Shepherd, J., & Ridker, P. M. (2010) · Annals of Internal Medicine

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 252

Association of Incident Alzheimer Disease and Blood Pressure Measured From 13 Years Before to 2 Years After Diagnosis in a Large Community Study

Morris, M. C., Scherr, P. A., Hebert, L. E., Glynn, R. J., Bennett, D. A., & Evans, D. A. (2001) · Archives of Neurology

Dementia and Cognitive Impairment ResearchBlood Pressure and Hypertension Studies

Cited by 217

Multivitamins in the Prevention of Cardiovascular Disease in Men: The Physicians' Health Study II Randomized Controlled Trial

Sesso, H. D., Christen, W. G., Bubes, V., Smith, J. P., MacFadyen, J., Schvartz, M., Manson, J. E., Glynn, R. J., Buring, J. E., & Gaziano, J. M. (2012) · JAMA

Nutrition and Health StudiesNutritional Studies and Diet

Cited by 208

Dopamine Antagonists and the Development of Breast Cancer

Wang, P. S., Walker, A. M., Tsuang, M. T., Orav, E. J., Glynn, R. J., Levin, R., & Avorn, J. (2002) · Archives of General Psychiatry

Schizophrenia research and treatmentCancer Risks and Factors

Cited by 196

Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center

Eberly, L. A., Richterman, A., Beckett, A. G., Wispelwey, B., Marsh, R. H., Cleveland Manchanda, E. C., Chang, C. Y., Glynn, R. J., Brooks, K. C., Boxer, R., et al. (2019) · Circulation: Heart Failure

Heart Failure Treatment and ManagementHealth disparities and outcomes

Cited by 189

A Randomized Study of How Physicians Interpret Research Funding Disclosures

Kesselheim, A. S., Robertson, C. T., Myers, J. A., Rose, S. L., Gillet, V., Ross, K. M., Glynn, R. J., Joffe, S., & Avorn, J. (2012) · New England Journal of Medicine

Pharmaceutical industry and healthcareEthics in Clinical Research

Cited by 183

Effect of physical activity on serum C-reactive protein

Albert, M. A., Glynn, R. J., & Ridker, P. M. (2004) · The American Journal of Cardiology

Physical Activity and HealthExercise and Physiological Responses

Cited by 178